Differential effects of Mas receptor deficiency on cardiac function and blood pressure in obese male and female mice

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 312, Issue 3, 2017, Pages H459-H468

  Wang, Yu ^a   Shoemaker, Robin ^a   Powell, David ^a   Su, Wen ^a   Thatcher, Sean ^a   Cassis, Lisa A ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Angiotensin (1 7); Hypertension; Obesity

Indexed keywords

ANGIOTENSIN[1-7]; G PROTEIN COUPLED RECEPTOR; MAS RECEPTOR; RECOMBINANT ANGIOTENSIN[1-7]; UNCLASSIFIED DRUG; VASOCONSTRICTOR AGENT; ANGIOTENSIN I; ANGIOTENSIN I (1-7); ONCOPROTEIN; PEPTIDE FRAGMENT; PROTO-ONCOGENE PROTEINS C-MAS-1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET INDUCED OBESITY; DRUG INFUSION; FEEDING; FEMALE; GENOTYPE; HEART FUNCTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HYPERTENSION; LEFT VENTRICULAR FIBROSIS; LIPID DIET; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; WILD TYPE; ADVERSE EFFECTS; ANIMAL; BLOOD; C57BL MOUSE; COMPLICATION; DIAGNOSTIC IMAGING; ECHOCARDIOGRAPHY; GENETICS; HEART; HEART FUNCTION TEST; HEART LEFT VENTRICLE HYPERTROPHY; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PATHOPHYSIOLOGY;

ANGIOTENSIN I; ANIMALS; BLOOD PRESSURE; DIET, HIGH-FAT; ECHOCARDIOGRAPHY; FEMALE; HEART; HEART FUNCTION TESTS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OBESITY; PEPTIDE FRAGMENTS; PROTO-ONCOGENE PROTEINS; RECEPTORS, G-PROTEIN-COUPLED;

EID: 85014508000     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00498.2016     Document Type: Article

References (38)

1. Alpert MA, Lavie CJ, Agrawal H, Aggarwal KB, Kumar SA. Obesity and heart failure: epidemiology, pathophysiology, clinical manifestations, and management. Transl Res 164: 345–356, 2014. doi:10.1016/j.trsl.2014.04.010.
2. Alpert MA, Lavie CJ, Agrawal H, Kumar A, Kumar SA. Cardiac Effects of Obesity: PATHOPHYSIOLOGIC, CLINICAL, AND PROGNOSTIC CONSEQUENCES-A REVIEW. J Cardiopulm Rehabil Prev 36: 1–11, 2016. doi:10.1097/HCR.0000000000000147.
3. Barretti DL, Magalhães FC, Fernandes T, do Carmo EC, Rosa KT, Irigoyen MC, Negrão CE, Oliveira EM. Effects of aerobic exercise training on cardiac renin-angiotensin system in an obese Zucker rat strain. PLoS One 7: e46114, 2012. doi:10.1371/journal.pone.0046114.
4. Boustany CM, Bharadwaj K, Daugherty A, Brown DR, Randall DC, Cassis LA. Activation of the systemic and adipose renin-angiotensin system in rats with diet-induced obesity and hypertension. Am J Physiol Regul Integr Comp Physiol 287: R943–R949, 2004. doi:10.1152/ajpregu.00265.2004.
5. Dong F, Li Q, Sreejayan N, Nunn JM, Ren J. Metallothionein prevents high-fat diet induced cardiac contractile dysfunction: role of peroxisome proliferator activated receptor gamma coactivator 1alpha and mitochondrial biogenesis. Diabetes 56: 2201–2212, 2007. doi:10.2337/db06-1596.
6. Gava E, de Castro CH, Ferreira AJ, Colleta H, Melo MB, Alenina N, Bader M, Oliveira LA, Santos RA, Kitten GT. Angiotensin-(1–7) receptor Mas is an essential modulator of extracellular matrix protein expression in the heart. Regul Pept 175: 30–42, 2012. doi:10.1016/j.regpep.2012.01.001.
7. Giani JF, Muñoz MC, Mayer MA, Veiras LC, Arranz C, Taira CA, Turyn D, Toblli JE, Dominici FP. Angiotensin-(1–7) improves cardiac remodeling and inhibits growth-promoting pathways in the heart of fructose- fed rats. Am J Physiol Heart Circ Physiol 298: H1003–H1013, 2010. doi:10.1152/ajpheart.00803.2009.
8. Gomes ER, Lara AA, Almeida PW, Guimarães D, Resende RR, Campagnole- Santos MJ, Bader M, Santos RA, Guatimosim S. Angiotensin- (1–7) prevents cardiomyocyte pathological remodeling through a nitric oxide/ guanosine 3=,5=-cyclic monophosphate-dependent pathway. Hypertension 55: 153–160, 2010. doi:10.1161/HYPERTENSIONAHA.109.143255.
9. Gupte M, Boustany-Kari CM, Bharadwaj K, Police S, Thatcher S, Gong MC, English VL, Cassis LA. ACE2 is expressed in mouse adipocytes and regulated by a high-fat diet. Am J Physiol Regul Integr Comp Physiol 295: R781–R788, 2008. doi:10.1152/ajpregu.00183.2008.
10. Gupte M, Thatcher SE, Boustany-Kari CM, Shoemaker R, Yiannikouris F, Zhang X, Karounos M, Cassis LA. Angiotensin converting enzyme 2 contributes to sex differences in the development of obesity hypertension in C57BL/6 mice. Arterioscler Thromb Vasc Biol 32: 1392–1399, 2012. doi:10.1161/ATVBAHA.112.248559.
11. Kangussu LM, Guimaraes PS, Nadu AP, Melo MB, Santos RA, Campagnole-Santos MJ. Activation of angiotensin-(1–7)/Mas axis in the brain lowers blood pressure and attenuates cardiac remodeling in hypertensive transgenic (mRen2)27 rats. Neuropharmacology 97: 58–66, 2015. doi:10.1016/j.neuropharm.2015.04.036.
12. Kim D, Gilson WD, Kramer CM, Epstein FH. Myocardial tissue tracking with two-dimensional cine displacement-encoded MR imaging: development and initial evaluation. Radiology 230: 862–871, 2004. doi: 10.1148/radiol.2303021213.
13. Kotchen TA. Obesity-related hypertension: epidemiology, pathophysiology, and clinical management. Am J Hypertens 23: 1170–1178, 2010. doi:10.1038/ajh.2010.172.
14. Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol 53: 1925–1932, 2009. doi:10.1016/j.jacc.2008.12.068.
15. Lemos VS, Silva DM, Walther T, Alenina N, Bader M, Santos RA. The endothelium-dependent vasodilator effect of the nonpeptide Ang(1–7) mimic AVE 0991 is abolished in the aorta of mas-knockout mice. J Cardiovasc Pharmacol 46: 274–279, 2005. doi:10.1097/01.fjc.0000175237.41573.63.
16. Mori J, Patel VB, Abo Alrob O, Basu R, Altamimi T, Desaulniers J, Wagg CS, Kassiri Z, Lopaschuk GD, Oudit GY. Angiotensin 1–7 ameliorates diabetic cardiomyopathy and diastolic dysfunction in db/db mice by reducing lipotoxicity and inflammation. Circ Heart Fail 7: 327–339, 2014. doi:10.1161/CIRCHEARTFAILURE.113.000672.
17. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 355: 251–259, 2006. doi:10.1056/NEJMoa052256.
18. Papinska AM, Soto M, Meeks CJ, Rodgers KE. Long-term administration of angiotensin (1–7) prevents heart and lung dysfunction in a mouse model of type 2 diabetes (db/db) by reducing oxidative stress, inflammation and pathological remodeling. Pharmacol Res 107: 372–380, 2016. doi:10.1016/j.phrs.2016.02.026.
19. Patel VB, Mori J, McLean BA, Basu R, Das SK, Ramprasath T, Parajuli N, Penninger JM, Grant MB, Lopaschuk GD, Oudit GY. ACE2 Deficiency Worsens Epicardial Adipose Tissue Inflammation and Cardiac Dysfunction in Response to Diet-Induced Obesity. Diabetes 65: 85–95, 2016. doi:10.2337/db15-0399.
20. Rabello Casali K, Ravizzoni Dartora D, Moura M, Bertagnolli M, Bader M, Haibara A, Alenina N, Irigoyen MC, Santos RA. Increased vascular sympathetic modulation in mice with Mas receptor deficiency. J Renin Angiotensin Aldosterone Syst 17: 1470320316643643, 2016. doi: 10.1177/1470320316643643.
21. Rider OJ, Lewandowski A, Nethononda R, Petersen SE, Francis JM, Pitcher A, Holloway CJ, Dass S, Banerjee R, Byrne JP, Leeson P, Neubauer S. Gender-specific differences in left ventricular remodelling in obesity: insights from cardiovascular magnetic resonance imaging. Eur Heart J 34: 292–299, 2013. doi:10.1093/eurheartj/ehs341.
22. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, Carnethon MR, Dai S, de Simone G, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Greenlund KJ, Hailpern SM, Heit JA, Ho PM, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, McDermott MM, Meigs JB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Rosamond WD, Sorlie PD, Stafford RS, Turan TN, Turner MB, Wong ND, Wylie-Rosett J, Roger VL, Turner MB; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics–2011 update: a report from the American Heart Association. Circulation 123: e18–e209, 2011. doi:10.1161/CIR.0b013e3182009701.
23. Sampaio WO, Souza dos Santos RA, Faria-Silva R, da Mata Machado LT, Schiffrin EL, Touyz RM. Angiotensin-(1–7) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways. Hypertension 49: 185–192, 2007. doi:10.1161/01.HYP.0000251865.35728.2f.
24. Santos RA, Castro CH, Gava E, Pinheiro SV, Almeida AP, Paula RD, Cruz JS, Ramos AS, Rosa KT, Irigoyen MC, Bader M, Alenina N, Kitten GT, Ferreira AJ. Impairment of in vitro and in vivo heart function in angiotensin-(1–7) receptor MAS knockout mice. Hypertension 47: 996–1002, 2006. doi:10.1161/01.HYP.0000215289.51180.5c.
25. Santos SH, Giani JF, Burghi V, Miquet JG, Qadri F, Braga JF, Todiras M, Kotnik K, Alenina N, Dominici FP, Santos RA, Bader M. Oral administration of angiotensin-(1–7) ameliorates type 2 diabetes in rats. J Mol Med (Berl) 92: 255–265, 2014. doi:10.1007/s00109-013-1087-0.
26. Shoemaker R, Yiannikouris F, Thatcher S, Cassis L. ACE2 deficiency reduces β-cell mass and impairs β-cell proliferation in obese C57BL/6 mice. Am J Physiol Endocrinol Metab 309: E621–E631, 2015. doi:10.1152/ajpendo.00054.2015.
27. Song X, Tabák AG, Zethelius B, Yudkin JS, Söderberg S, Laatikainen T, Stehouwer CD, Dankner R, Jousilahti P, Onat A, Nilsson PM, Satman I, Vaccaro O, Tuomilehto J, Qiao Q; DECODE Study Group. Obesity attenuates gender differences in cardiovascular mortality. Cardiovasc Diabetol 13: 144, 2014. doi:10.1186/s12933-014-0144-5.
28. Sullivan JC, Rodriguez-Miguelez P, Zimmerman MA, Harris RA. Differences in angiotensin (1–7) between men and women. Am J Physiol Heart Circ Physiol 308: H1171–H1176, 2015. doi:10.1152/ajpheart.00897.2014.
29. Sung MM, Koonen DP, Soltys CL, Jacobs RL, Febbraio M, Dyck JR. Increased CD36 expression in middle-aged mice contributes to obesityrelated cardiac hypertrophy in the absence of cardiac dysfunction. J Mol Med (Berl) 89: 459–469, 2011. doi:10.1007/s00109-010-0720-4.
30. Thakker GD, Frangogiannis NG, Bujak M, Zymek P, Gaubatz JW, Reddy AK, Taffet G, Michael LH, Entman ML, Ballantyne CM. Effects of diet-induced obesity on inflammation and remodeling after myocardial infarction. Am J Physiol Heart Circ Physiol 291: H2504–H2514, 2006. doi:10.1152/ajpheart.00322.2006.
31. -/- mice. Arterioscler Thromb Vasc Biol 31: 758–765, 2011. doi:10.1161/ATVBAHA.110.221614.
32. Turdi S, Kandadi MR, Zhao J, Huff AF, Du M, Ren J. Deficiency in AMP-activated protein kinase exaggerates high fat diet-induced cardiac hypertrophy and contractile dysfunction. J Mol Cell Cardiol 50: 712–722, 2011. doi:10.1016/j.yjmcc.2010.12.007.
33. Walther T, Wessel N, Kang N, Sander A, Tschöpe C, Malberg H, Bader M, Voss A. Altered heart rate and blood pressure variability in mice lacking the Mas protooncogene. Braz J Med Biol Res 33: 1–9, 2000. doi:10.1590/S0100-879X2000000100001.
34. Wang Y, Shoemaker R, Thatcher SE, Batifoulier-Yiannikouris F, English VL, Cassis LA. Administration of 17β-estradiol to ovariectomized obese female mice reverses obesity-hypertension through an ACE2- dependent mechanism. Am J Physiol Endocrinol Metab 308: E1066–E1075, 2015. doi:10.1152/ajpendo.00030.2015.
35. Williams IM, Otero YF, Bracy DP, Wasserman DH, Biaggioni I, Arnold AC. Chronic Angiotensin-(1–7) Improves Insulin Sensitivity in High-Fat Fed Mice Independent of Blood Pressure. Hypertension 67: 983–991, 2016. doi:10.1161/HYPERTENSIONAHA.115.06935.
36. Xu P, Costa-Goncalves AC, Todiras M, Rabelo LA, Sampaio WO, Moura MM, Santos SS, Luft FC, Bader M, Gross V, Alenina N, Santos RA. Endothelial dysfunction and elevated blood pressure in MAS gene-deleted mice. Hypertension 51: 574–580, 2008. doi:10.1161/HYPERTENSIONAHA.107.102764.
37. Yiannikouris F, Karounos M, Charnigo R, English VL, Rateri DL, Daugherty A, Cassis LA. Adipocyte-specific deficiency of angiotensinogen decreases plasma angiotensinogen concentration and systolic blood pressure in mice. Am J Physiol Regul Integr Comp Physiol 302: R244–R251, 2012. doi:10.1152/ajpregu.00323.2011.
38. Zhang Y, Yuan M, Bradley KM, Dong F, Anversa P, Ren J. Insulinlike growth factor 1 alleviates high-fat diet-induced myocardial contractile dysfunction: role of insulin signaling and mitochondrial function. Hypertension 59: 680–693, 2012. doi:10.1161/HYPERTENSIONAHA.111.181867.